Ignite Creation Date:
2024-05-06 @ 6:42 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05753137
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-01-29
Brief Title:
Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial
Sponsor:
China Medical University Hospital
Organization:
China Medical University Hospital
Study Overview
Official Title:
Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial used acupuncture as an adjunctive treatment for glaucoma patients A randomized controlled trial involving 50 subjects will be conducted and observed for 12 weeks to evaluate the clinical efficacy of acupuncture This study aims to provide a reference for future clinical treatment guidelines
Detailed Description:
This clinical trial utilized acupuncture as an adjunctive treatment for glaucoma patients It is estimated a randomized clinical trial that 50 subjects will be enrolled and observed for 12 weeks to evaluate the clinical efficacy of acupuncture providing a reference for future clinical treatment guidelines Participants will be randomly divided into two groups Ophthalmic Acupoint Treatment Group and Non-ophthalmological Acupoint Control Group Participants in the treatment group will undergo acupuncture targeting ophthalmology-related acupuncture points aiming to elicit the De Qi sensation Conversely the control group will receive minimum acupuncture stimulation targeting non-ophthalmic acupuncture points without the intention of achieving the De Qi sensation Both groups will undergo acupuncture therapy once a week for a total of six sessions and will be observed for twelve weeks On each visit intraocular pressure blood pressure and heart rate will be assessed Questionnaires of Glaucoma Symptom Scale GSS and The Glaucoma Quality of Life-15 GQL-15 will be performed The data of central corneal thickness optical coherence tomography angiography optical coherence tomography visual field and best-corrected visual acuity will be collected and analyzed before acupuncture and in the 12th week
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None